Anti-p53 Purified

*Bartek J, Bartkova J, Vojtesek B, Staskova Z, Lukas J, Rejthar A, Kovarik J, Midgley CA, Gannon JV, Lane DP: Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene. 1991 Sep;6 (9) :1699-703., URL: https://www.ncbi.nlm.nih.gov/pubmed/1923535?dopt=A, *Bartkova J, Bartek J, Lukas J, Vojtesek B, Staskova Z, Rejthar A, Kovarik J, Midgley CA, Lane DP: p53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia. Int J Cancer. 1991 Sep 9;49 (2) :196-202., URL: https://www.ncbi.nlm.nih.gov/pubmed/1652567?dopt=A, *Rössner P Jr, Binková B, Chvátalová I, Srám RJ: Acrylonitrile exposure: the effect on p53 and p21 (WAF1) protein levels in the blood plasma of occupationally exposed workers and in vitro in human diploid lung fibroblasts. Mutat Res. 2002 May 27;517 (1-2) :239-50., URL: https://www.ncbi.nlm.nih.gov/pubmed/12034325 , *Dolezalova H, Vojtesek B, Kovarik J: Epitope analysis of the human p53 tumour suppressor protein. Folia Biol (Praha) . 1997;43 (1) :49-51. , URL: https://www.ncbi.nlm.nih.gov/pubmed/9158951?dopt=A

*Agarwal ML, Agarwal A, Taylor WR, Stark GR: p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci U S A. 1995 Aug 29;92 (18) :8493-7., URL: https://www.ncbi.nlm.nih.gov/pubmed/7667317?ordina, *Agarwal ML, Agarwal A, Taylor WR, Chernova O, Sharma Y, Stark GR: A p53-dependent S-phase checkpoint helps to protect cells from DNA damage in response to starvation for pyrimidine nucleotides. Proc Natl Acad Sci U S A. 1998 Dec 8;95 (25) :14775-80., URL: https://www.ncbi.nlm.nih.gov/pubmed/9843965?ordina, *Taylor WR, DePrimo SE, Agarwal A, Agarwal ML, Schönthal AH, Katula KS, Stark GR: Mechanisms of G2 arrest in response to overexpression of p53. Mol Biol Cell. 1999 Nov;10 (11) :3607-22., URL: https://www.ncbi.nlm.nih.gov/pubmed/10564259?ordin, *Taylor WR, Agarwal ML, Agarwal A, Stacey DW, Stark GR: p53 inhibits entry into mitosis when DNA synthesis is blocked. Oncogene. 1999 Jan 14;18 (2) :283-95., URL: https://www.ncbi.nlm.nih.gov/pubmed/9927185?ordina, *Tanigawa S, Fujii M, Hou DX: Stabilization of p53 is involved in quercetin-induced cell cycle arrest and apoptosis in HepG2 cells. Biosci Biotechnol Biochem. 2008 Mar;72 (3) :797-804., URL: https://www.ncbi.nlm.nih.gov/pubmed/18323654?ordin

The antibody BP53-12 recognizes a defined epitope (aa 16-25) on human p53, a 50 kDa intracellular tumour suppressor found in increased amounts in a wide variety of transformed cells; it is frequently mutated or inactivated in many types of cancer.